4//SEC Filing
Gall Matthew 4
Accession 0001209191-21-071435
CIK 0001808865other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 8:58 PM ET
Size
5.0 KB
Accession
0001209191-21-071435
Insider Transaction Report
Form 4
Gall Matthew
Chief Financial Officer
Transactions
- Sale
Common Stock
2021-12-27$46.45/sh−5,000$232,250→ 14,429 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.20 to $46.77, inclusive. The reporting person undertakes to provide to iTeos Therapeutics, Inc., any security holder of iTeos Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816194
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 8:58 PM ET
- Size
- 5.0 KB